Bayer Aktiengesellschaft (BAYZF)
OTCMKTS · Delayed Price · Currency is USD
44.48
-0.45 (-1.00%)
Jan 6, 2026, 4:00 PM EST
Bayer Aktiengesellschaft Employees
Bayer Aktiengesellschaft had 91,864 employees as of December 31, 2024. The number of employees decreased by 5,067 or -5.23% compared to the previous year.
Employees
91,864
Change (1Y)
-5,067
Growth (1Y)
-5.23%
Revenue / Employee
$608,058
Profits / Employee
-$2,625
Market Cap
43.68B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 91,864 | -5,067 | -5.23% |
| Dec 31, 2023 | 96,931 | -991 | -1.01% |
| Dec 31, 2022 | 97,922 | 1,972 | 2.06% |
| Dec 31, 2021 | 95,950 | -5 | -0.01% |
| Dec 31, 2020 | 95,955 | -2,782 | -2.82% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| American Oncology Network | 1,914 |
| Jushi Holdings | 1,234 |
| Glass House Brands | 374 |
| Silence Therapeutics | 116 |
| Elite Pharmaceuticals | 68 |
| Northwest Biotherapeutics | 25 |
| CytoDyn | 13 |
| OpGen | 1 |
Bayer Aktiengesellschaft News
- 1 day ago - Bayer sues COVID vaccine makers over mRNA technology - Reuters
- 1 day ago - Pesticide industry ‘immunity shield’ stripped from US appropriations bill - The Guardian
- 2 days ago - Bayer to Present Updates on Pharma Growth Strategy and Pipeline Advancements at J.P. Morgan's 44th Annual Healthcare Conference - Business Wire
- 7 days ago - BAYRY's 2025 Revival: Will the Momentum Continue in 2026? - Nasdaq
- 25 days ago - Bayer: Is This The Turning Point Investors Have Been Waiting For? - Seeking Alpha
- 27 days ago - DCM Shriram shares rally sharply 6% as company signs strategic MoU with Bayer to boost agri-innovation - Business Upturn
- 4 weeks ago - DCM Shriram and Bayer Crop Science sign strategic MoU to advance sustainable agriculture in India - Business Upturn
- 4 weeks ago - Bayer Starts Phase IIa Study for Treatment of Patients With Alport Syndrome - Business Wire